Penter Lab Cancer and immune cell co-evolution at Charité - Universitätsmedizin Berlin

Blog

The Penter Lab is opening in 2023. Updates on its progress can be found below.

2024

PhD position available!

We have an opening for a PhD position.

first Penter lab publication!

Exciting times - the first publication from the Penter lab has been released in which we review current studies that employ single cell genomics for performing immune monitoring in blood malignancies.

Funding from DKMS

We are grateful for funding from the DKMS John Hansen Research Grant, which we will utilize to track the beginnings of AML relapse after allogeneic stem cell transplantation.

Welcome Jonas

Welcome Jonas in our lab. Jonas will utilize long-read sequencing and single cell genomics to identify novel immunotherapeutic targets in AML. Good luck!

Welcome Angelos

Welcome Angelos in our lab. Angelos will work on single cell genomics approaches to understand clonal evolution and changes in transcriptional profile.

Postdoc position available!

We have an opening for a postdoctoral research fellow position.

nanoranger released!

The new year is starting with great news - nanoranger is seeing the light of day!

2023

Maylis joining

Maylis TOUMI from Agroparistech in France is joining us for her masters studies in Health Engineering. Maylis will work on distinguishing donor- from recipient-derived single cells. Welcome Maylis!

PhD position available!

We have two PhD positions available for projects that will focus on interactions between leukemia and immune cells. In the first project, we will utilize natural genetic barcodes to track leukemia evolution before and after immunotherapeutic bottlenecks such as allogeneic hematopoietic stem cell transplantation. In the second project, we will long-read sequencing to better understand alternative splicing in AML and to use this approach for the identification of novel immunotherapeutic targets. Looking forward to your application!

Funding from Else Kröner-Fresenius-Stiftung

We are super excited about the news that Else Kröner-Fresenius-Stiftung has decided to fund our proposal to use long-read single cell sequencing technologies to identify novel immunotherapeutic targets in AML/MDS. We’ll soon look for a PhD student who will work on this exciting project. Stay tuned!

Lena joining

Welcome Lena in the Penter lab! Lena will work on biobanking, general lab management and the wet lab side.

Max-Eder Research Group funding from German Cancer Aid foundation (Deutsche Krebshilfe)

We are grateful for research funding from the German Cancer Aid Max-Eder Program that will provide us with a generous start-up package for the first 4 years. Prof. Dr. med. Florian Heidel (Hannover) will serve as mentor for the group - thank you!

Funding from BIH Charité Digital Clinician Scientist Program

We are grateful for research funding from the BIH Charité Digital Clinician Scientist Program that will provide Livius with 50% protected research time for a period of 3 years. A big thank you to Prof. Dr. med. Frederik Damm and Prof. Dr. rer. nat. Nils Blüthgen for supporting the application!